Page last updated: 2024-10-25

amphetamine and ALS - Amyotrophic Lateral Sclerosis

amphetamine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Research Excerpts

ExcerptRelevanceReference
""Amphetamine exposure" was defined as a prior use of amphetamine, methamphetamine or dextroamphetamine."1.33Amphetamine exposure is elevated in Parkinson's disease. ( Bekele, W; Christine, CW; Garwood, ER; McCulloch, CE, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JK1
Dedeoglu, A1
Jenkins, BG1
Garwood, ER1
Bekele, W1
McCulloch, CE1
Christine, CW1

Other Studies

2 other studies available for amphetamine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Longitudinal monitoring of motor neuron circuitry in FALS rats using in-vivo phMRI.
    Neuroreport, 2010, Feb-17, Volume: 21, Issue:3

    Topics: Amphetamine; Amyotrophic Lateral Sclerosis; Animals; Brain Mapping; Central Nervous System Stimulant

2010
Amphetamine exposure is elevated in Parkinson's disease.
    Neurotoxicology, 2006, Volume: 27, Issue:6

    Topics: Adrenergic Agents; Aged; Amphetamine; Amphetamine-Related Disorders; Amyotrophic Lateral Sclerosis;

2006